Prostatype Genomics AB performs a directed share issue to guarantors in connection with the completed preferential share issue
THIS PRESS RELEASE MAY NOT BE DISCLOSED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY IN OR TO AUSTRALIA, BELARUS, HONGKONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SOUTH AFRICA, SWITZERLAND, SINGAPORE, USA, OR ANY OTHER JURISDICTION WHERE SUCH ACTION IS IN WHOLE OR IN PART FOR LEGAL RESTRICTIONS. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO ACQUIRE SECURITIES IN PROSTATYPE GENOMICS AB. SEE ALSO THE “IMPORTANT INFORMATION” SECTION BELOW. Prostatype Genomics AB ("Prostatype Genomics" or the "Company") announces that the Company's board, with the support of the authorization from the